Trump Signals Progress on Iran Nuclear Deal Strait of Hormuz Reopening in Focus
US Productivity Growth Moderates in Q4 as Labor Costs Rise What It Means for Inflation and Earnings
University of Manchester to Offer Work Placements Across All Degree Programs
SP 500 and Nasdaq Rebound on Report of USIran Peace Breakthrough Oil Pulls Back
ColgatePalmolive India Reports Marginal Q4 Profit Decline FullYear FY26 Revenue Dips to Rs 6124 Crore
Disneys The Mandalorian and Grogu Opens to 82M Lowest in Star Wars Franchise History
BILL Q1 2026 Earnings EPS Surprises to the Upside Stock Declines Despite Beat
Gentex Corporation GNTX Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Decline
FULTP Q1 2026 Earnings Preferred Stock Delivers EPS Beat Despite Market Headwinds
PAGP Q1 2026 Earnings Strong EPS Surprise of 11972 Drives Positive Stock Movement
RSG Q1 2026 Earnings EPS Beat Driven by Operational Efficiency
BOTJ Q1 2025 Earnings EPS of 019 Reported Stock Edges Higher
New Mountain Finance Corporation 8250 Notes due 2028 NMFCZ Holds Steady at 2527 Amidst Stable Trading
authID Inc AUID Slips Lower Amidst Narrow Trading Range Key Support Level in Focus
UGI Corporation Faces Headwinds Stock Declines Over 2 Amid Sector Pressure
BRC Inc BRCC Dips Past Key Levels as Volume Increases
Silvercorp Metals SVM Surges Over 28 as Silver Prices Rally Key Levels to Watch
Qualcomm Stock Surge Reflects Growing Investor Interest in AI Device Expansion
SPME Q1 2026 Earnings EPS Misses Estimates by Nearly 20 as Preferred Shares Edge Lower
STRATTEC Security STRT Maintains Uptrend With Modest Gain Key Levels in Focus
HAFC Q1 2026 Earnings EPS Beats Estimates by 478 Amid Challenging Banking Environment
OPTU Q1 2026 Earnings Massive EPS Miss as Company Reports Unexpectedly Wide Loss
TRS Q1 2026 Earnings EPS Beats Estimates by 2539
BKD Q1 2026 Earnings EPS Misses Estimates Stock Declines
Medallion Financial Corp MFIN Q1 2026 Earnings Profitability Miss Pressures the Stock
Stevanato Group Q1 2026 Earnings EPS Beats Estimates Amid Operational Gains
Compass Therapeutics Q1 2026 Earnings Narrowerthanexpected Loss Fuels Investor Optimism